Research use only. Not for human or veterinary use.
Lab reports
Analysis reportAll specifications met

Retatrutide 40mg

Peptide Stock ref. PSV-2609-RT40-01

Lot
CP01260817240L
Manufactured
17 August 2026
Tested by
Accumark Labs
Analysed
23 September 2026
Purity99.95%HPLC
Content per vial40.202 mg100.5% of 40 mg label claim
IdentityConfirmedHPLC

Test results

TestSpecificationResultOutcome
Purity (HPLC)—99.947%Pass
IdentityRetatrutideConformsPass
Quantity per vialMeasured40.202 mg (100.5% of claim)Reported

About this report

← All lab reports